VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SLPSimulations Plus, Inc.
$18.24$367M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

SLP logoSimulations Plus, Inc.(SLP)Earnings, Financials & Key Ratios

SLP•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryLife Sciences and Precision Medicine Software
AboutSimulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.Show more
  • Revenue$79M+13.1%
  • EBITDA-$63M-630.0%
  • Net Income-$65M-750.2%
  • EPS (Diluted)-3.22-757.1%
  • Gross Margin58.38%-5.3%
  • EBITDA Margin-78.96%-568.6%
  • Operating Margin-89.33%-1120.1%
  • Net Margin-81.74%-674.9%
  • ROE-42.13%-845.9%

SLP Key Insights

Simulations Plus, Inc. (SLP) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓FCF machine: 22.0% free cash flow margin
  • ✓Momentum leader: RS Rating 81 (top 19%)
  • ✓Strong 5Y sales CAGR of 13.7%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when SLP posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

SLP Price & Volume

Simulations Plus, Inc. (SLP) stock price & volume — 10-year historical chart

Loading chart...

SLP Growth Metrics

Simulations Plus, Inc. (SLP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years15.77%
5 Years13.74%
3 Years13.67%
TTM5.69%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-882.08%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-895.72%

Return on Capital

10 Years9.99%
5 Years-4.17%
3 Years-12.01%
Last Year-44.1%

SLP Recent Earnings

Simulations Plus, Inc. (SLP) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Apr 9, 2026
Metric
Actual
Est
EPS
$0.35+29.6%
$0.27
Rev
$24M+12.2%
$22M
Q1 2026
Jan 8, 2026
Metric
Actual
Est
EPS
$0.13-27.8%
$0.18
Rev
$18M+2.0%
$18M
Q4 2025
Dec 1, 2025
Metric
Actual
Est
EPS
$0.10+0.0%
$0.10
Rev
$17M+0.4%
$17M
Q3 2025
Jul 14, 2025
Metric
Actual
Est
EPS
$0.45+73.1%
$0.26
Rev
$20M-2.7%
$21M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 9, 2026
$0.35vs $0.27+29.6%
$24Mvs $22M+12.2%
Q1 2026Jan 8, 2026
$0.13vs $0.18-27.8%
$18Mvs $18M+2.0%
Q4 2025Dec 1, 2025
$0.10vs $0.10+0.0%
$17Mvs $17M+0.4%
Q3 2025Jul 14, 2025
$0.45vs $0.26+73.1%
$20Mvs $21M-2.7%
Based on last 12 quarters of dataView full earnings history →

SLP Peer Comparison

Simulations Plus, Inc. (SLP) competitors in Life Sciences and Precision Medicine Software — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
VEEV logoVEEVVeeva Systems Inc.Direct Competitor24.9B153.3028.1816.34%28.37%13.36%0.01
CERT logoCERTCertara, Inc.Direct Competitor861.83M5.54-5548.75%-3.6%-1.43%0.01
SCYX logoSCYXSCYNEXIS, Inc.Direct Competitor25.47M4.05-2.98449.95%-120.51%-57.16%0.04
DSGN logoDSGNDesign Therapeutics, Inc.Product Competitor776.96M12.44-10.20-33.07%0.00
SDGR logoSDGRSchrödinger, Inc.Product Competitor1.18B15.76-11.1823.29%-40.6%-30.85%0.30
RXRX logoRXRXRecursion Pharmaceuticals, Inc.Product Competitor1.44B3.23-2.2426.92%-8.44%-54.32%0.07
ABSI logoABSIAbsci CorporationProduct Competitor1.16B7.41-8.82-38.24%-64.51%-63.58%0.03
TMO logoTMOThermo Fisher Scientific Inc.Supply Chain172.66B464.6126.193.91%15.18%13.23%0.76

Compare SLP vs Peers

Simulations Plus, Inc. (SLP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs VEEV

Most directly comparable listed peer for SLP.

Scale Benchmark

vs TMO

Larger-name benchmark to compare SLP against a more recognizable public peer.

Peer Set

Compare Top 5

vs VEEV, CERT, SCYX, DSGN

SLP Income Statement

Simulations Plus, Inc. (SLP) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricAug'17Aug'18Aug'19Aug'20Aug'21Aug'22Aug'23Aug'24Aug'25TTM
Sales/Revenue
24.14M29.67M33.97M41.59M46.47M53.91M59.58M70.01M79.18M78.68M
Revenue Growth %
20.86%22.9%14.51%22.43%11.73%16.01%10.52%17.52%13.09%5.69%
Cost of Goods Sold
6.31M7.99M9.03M10.65M10.6M10.82M11.63M26.86M32.96M31.78M
COGS % of Revenue
26.13%26.95%26.57%25.61%22.81%20.08%19.52%38.37%41.62%-
Gross Profit
17.83M▲ 0%
21.67M▲ 21.5%
24.94M▲ 15.1%
30.94M▲ 24.0%
35.87M▲ 15.9%
43.08M▲ 20.1%
47.95M▲ 11.3%
43.15M▼ 10.0%
46.22M▲ 7.1%
46.89M▲ 0%
Gross Margin %
73.87%73.05%73.43%74.39%77.19%79.92%80.48%61.63%58.38%59.6%
Gross Profit Growth %
16%21.55%15.1%24.04%15.92%20.12%11.29%-10%7.11%-
Operating Expenses
9.57M11.37M14.3M19.34M24.61M28.17M39.22M37.02M116.95M117.04M
OpEx % of Revenue
39.63%38.34%42.08%46.49%52.97%52.26%65.83%52.88%147.7%-
Selling, General & Admin
8.2M9.58M11.8M16.36M20.57M24.96M34.72M31.27M32.84M31.8M
SG&A % of Revenue
33.96%32.31%34.72%39.34%44.26%46.31%58.27%44.66%41.48%-
Research & Development
1.37M1.79M2.5M2.98M4.05M3.21M4.5M5.75M6.88M8.02M
R&D % of Revenue
5.67%6.04%7.36%7.15%8.71%5.95%7.56%8.22%8.69%-
Other Operating Expenses
0000000077.22M1000K
Operating Income
8.26M▲ 0%
10.3M▲ 24.6%
10.65M▲ 3.4%
11.61M▲ 9.0%
11.25M▼ 3.0%
14.91M▲ 32.5%
8.72M▼ 41.5%
6.13M▼ 29.7%
-70.73M▼ 1253.6%
-70.14M▲ 0%
Operating Margin %
34.24%34.71%31.35%27.9%24.22%27.66%14.64%8.76%-89.33%-89.15%
Operating Income Growth %
14.28%24.61%3.4%8.99%-3.03%32.51%-41.49%-29.73%-1253.63%-
EBITDA
10.4M13.02M13.4M14.57M14.84M18.48M12.56M11.8M-62.52M-62.85M
EBITDA Margin %
43.08%43.88%39.44%35.03%31.94%34.29%21.09%16.85%-78.96%-79.88%
EBITDA Growth %
13.48%25.19%2.91%8.73%1.89%24.54%-32.03%-6.12%-629.99%-617.88%
D&A (Non-Cash Add-back)
2.14M2.72M2.75M2.96M3.59M3.57M3.84M5.67M8.21M7.29M
EBIT
8.28M10.3M10.56M11.39M11.11M15.12M9.22M6.13M6.49M7.34M
Net Interest Income
-22.33K27.12K34K30K179K717K4.13M4.38M722K830K
Interest Income
15.86K27.12K34K30K201K717K4.13M4.38M722K830K
Interest Expense
38.19K00022K00000
Other Income/Expense
-24.02K-158.85K-92K-218K-168K204K2.97M6.28M1.35M1.47M
Pretax Income
8.24M▲ 0%
10.14M▲ 23.0%
10.56M▲ 4.1%
11.39M▲ 7.9%
11.09M▼ 2.7%
15.12M▲ 36.4%
11.7M▼ 22.6%
12.41M▲ 6.1%
-69.38M▼ 659.0%
-68.68M▲ 0%
Pretax Margin %
34.14%34.18%31.07%27.38%23.86%28.04%19.63%17.73%-87.62%-87.29%
Income Tax
2.45M1.2M1.97M2.06M1.3M2.63M1.73M2.46M-4.66M-4.43M
Effective Tax Rate %
29.76%11.88%18.69%18.05%11.75%17.41%14.83%19.8%6.72%6.45%
Net Income
5.79M▲ 0%
8.93M▲ 54.4%
8.58M▼ 3.9%
9.33M▲ 8.7%
9.78M▲ 4.8%
12.48M▲ 27.6%
9.96M▼ 20.2%
9.95M▼ 0.1%
-64.72M▼ 750.2%
-64.25M▲ 0%
Net Margin %
23.98%30.12%25.27%22.44%21.05%23.16%16.72%14.22%-81.74%-81.66%
Net Income Growth %
16.92%54.38%-3.94%8.73%4.82%27.61%-20.2%-0.07%-750.17%-882.08%
Net Income (Continuing)
5.79M8.93M8.58M9.33M9.78M12.48M9.96M9.95M-64.72M-64.25M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
0.33▲ 0%
0.50▲ 51.5%
0.48▼ 4.0%
0.50▲ 4.2%
0.47▼ 6.0%
0.60▲ 27.7%
0.49▼ 18.3%
0.49▲ 0.0%
-3.22▼ 757.1%
-3.18▲ 0%
EPS Growth %
13.79%51.52%-4%4.17%-6%27.66%-18.33%0%-757.14%-895.72%
EPS (Basic)
0.340.520.490.520.490.620.500.50-3.22-
Diluted Shares Outstanding
17.52M17.86M18.06M18.54M20.74M20.75M20.46M20.3M20.1M20.22M
Basic Shares Outstanding
17.24M17.33M17.49M17.82M20.05M20.2M20.07M19.99M20.1M20.14M
Dividend Payout Ratio
59.58%46.58%48.9%45.55%49.18%38.82%48.28%48.18%--

SLP Balance Sheet

Simulations Plus, Inc. (SLP) balance sheet — assets, liabilities & shareholders' equity

MetricAug'17Aug'18Aug'19Aug'20Aug'21Aug'22Aug'23Aug'24Aug'25TTM
Total Current Assets
12.67M17.82M21.17M129.09M139.31M146.79M130.37M39.34M51.55M58.14M
Cash & Short-Term Investments
6.22M9.4M11.44M116.01M123.6M128.24M115.46M20.25M32.35M35.69M
Cash Only
6.22M9.4M11.44M49.21M36.98M51.57M57.52M10.31M30.85M30.19M
Short-Term Investments
00066.8M86.62M76.67M57.94M9.94M1.5M5.5M
Accounts Receivable
5.53M7.5M8.26M10.52M13.05M13.79M10.2M9.14M14.62M12.15M
Days Sales Outstanding
83.6292.2888.7592.28102.5293.3562.547.6367.3867.32
Inventory
462.44K312.59K765.11K969.69K1.01M1.39M804K000
Days Inventory Outstanding
26.7614.2730.9433.2434.8546.9225.23---
Other Current Assets
459.9K610.44K704.32K1.6M1.65M3.38M3.9M7.75M2.8M10.3M
Total Non-Current Assets
25.84M26.33M24.93M40.73M42.3M43.71M62.27M168.3M80.39M79.69M
Property, Plant & Equipment
291.13K335.22K341.14K1.36M3.11M2.05M1.92M1.84M1.29M1.18M
Fixed Asset Turnover
82.91x88.50x99.58x30.48x14.92x26.27x31.06x38.07x61.52x60.49x
Goodwill
10.39M10.39M10.39M12.92M12.92M12.92M19.1M96.08M43.72M43.72M
Intangible Assets
15.13M14.7M13.27M24.99M24.58M26.18M32.85M58.84M29.21M28.8M
Long-Term Investments
0000000000
Other Non-Current Assets
34.08K37.23K37.23K50.97K51K439K425K542K1.4M1.38M
Total Assets
38.51M▲ 0%
44.15M▲ 14.6%
46.09M▲ 4.4%
169.82M▲ 268.4%
181.61M▲ 6.9%
190.5M▲ 4.9%
192.64M▲ 1.1%
207.64M▲ 7.8%
131.94M▼ 36.5%
137.83M▲ 0%
Asset Turnover
0.63x0.67x0.74x0.24x0.26x0.28x0.31x0.34x0.60x0.52x
Asset Growth %
38.46%14.64%4.41%268.41%6.95%4.89%1.12%7.78%-36.46%-92.89%
Total Current Liabilities
2.04M4.83M4.78M5.5M11.57M7.74M11.99M12.07M6.72M10.34M
Accounts Payable
240.89K351.61K204.07K351K387K225K144K602K470K863K
Days Payables Outstanding
13.9416.058.2512.0313.337.594.528.185.2112.06
Short-Term Debt
000463.46K382K461K442K475K206K179K
Deferred Revenue (Current)
570.92K766.53K1.18M440.47K651K2.86M3.1M2M2.7M16.11M
Other Current Liabilities
1.23M3.71M3.4M4.25M10.15M931K3.91M4.48M1.34M922K
Current Ratio
6.20x3.69x4.42x23.45x12.04x18.98x10.88x3.26x7.67x5.62x
Quick Ratio
5.98x3.63x4.26x23.28x11.95x18.80x10.81x3.26x7.67x5.62x
Cash Conversion Cycle
96.4490.5111.44113.49124.04132.6883.21--55.26
Total Non-Current Liabilities
10.67M7.4M3.63M8.28M4.26M4.52M10.62M13.14M410K378K
Long-Term Debt
0000000000
Capital Lease Obligations
000463.31K896K943K755K531K410K1.72M
Deferred Tax Liabilities
4.93M4.07M3.63M3.75M3.36M3.58M6.54M12.61M0701K
Other Non-Current Liabilities
5.74M3.33M04.06M003.33M000
Total Liabilities
12.71M12.23M8.41M13.78M15.83M12.26M22.61M25.21M7.13M10.72M
Total Debt
000926.78K1.28M1.4M1.2M1.01M616K557K
Net Debt
-6.22M-9.4M-11.44M-48.28M-35.71M-50.16M-56.33M-9.3M-30.24M-29.63M
Debt / Equity
---0.01x0.01x0.01x0.01x0.01x0.00x0.00x
Debt / EBITDA
---0.06x0.09x0.08x0.10x0.09x--0.01x
Net Debt / EBITDA
-0.60x-0.72x-0.85x-3.31x-2.41x-2.71x-4.48x-0.79x-0.47x
Interest Coverage
216.41x---511.50x-----
Total Equity
25.8M▲ 0%
31.92M▲ 23.7%
37.68M▲ 18.0%
156.04M▲ 314.1%
165.78M▲ 6.2%
178.25M▲ 7.5%
170.03M▼ 4.6%
182.43M▲ 7.3%
124.8M▼ 31.6%
127.11M▲ 0%
Equity Growth %
13.51%23.71%18.04%314.09%6.25%7.52%-4.61%7.29%-31.59%-87.26%
Book Value per Share
1.471.792.098.427.998.598.318.996.216.29
Total Shareholders' Equity
25.8M31.92M37.68M156.04M165.78M178.25M170.03M182.43M124.8M127.11M
Common Stock
7.28K7.42K7.59K9.93K133.42M138.51M144.97M20K20K20K
Retained Earnings
13.69M18.46M22.35M27.44M32.41M40.04M25.2M30.35M-34.36M-33.69M
Treasury Stock
0000000000
Accumulated OCI
00058.47K-43K-308K-141K-251K-271K-277K
Minority Interest
0000000000

SLP Cash Flow Statement

Simulations Plus, Inc. (SLP) cash flow — operating, investing & free cash flow history

MetricAug'17Aug'18Aug'19Aug'20Aug'21Aug'22Aug'23Aug'24Aug'25TTM
Cash from Operations
6.88M9.29M11.64M10.91M19.2M17.9M21.86M13.32M18.13M23.63M
Operating CF Margin %
28.49%31.31%34.26%26.24%41.33%33.21%36.69%19.02%22.89%-
Operating CF Growth %
27.01%35.03%25.32%-6.24%75.98%-6.79%22.1%-39.06%36.08%708.95%
Net Income
5.79M8.93M8.58M9.33M9.78M12.48M9.96M9.95M-64.72M-64.25M
Depreciation & Amortization
2.14M2.72M2.75M2.96M3.59M3.57M3.84M5.67M8.21M7.29M
Stock-Based Compensation
585.02K709.08K1.08M1.58M2.75M3.04M4.83M6.54M6.35M6.25M
Deferred Taxes
-178.37K-1.73M-299.1K-377.76K-628K-270K-2.1M-1.76M-5.43M-5.3M
Other Non-Cash Items
74.95K152.75K109.06K202.03K2.73M1.7M219K-2.86M76.29M76.44M
Working Capital Changes
-1.53M-1.5M-582.96K-2.78M974K-2.62M5.1M-4.21M-2.59M3.21M
Change in Receivables
-876.23K-1.47M487.97K-2.02M-2.43M-3.94M4.1M3.13M-581K650K
Change in Inventory
-378.99K-339.46K-1.31M-247.25K3.15M00000
Change in Payables
99.34K110.71K-147.53K220.58K39K-162K-81K-477K-132K-257K
Cash from Investing
-4.36M-2.33M-1.96M-75.51M-26.74M4.3M7.37M-53.97M3.56M1.8M
Capital Expenditures
-1.56M-2.33M-1.96M-2.58M-4.58M-3.97M-4.27M-566K-713K-1.53M
CapEx % of Revenue
6.46%7.85%5.76%6.21%9.85%7.36%7.17%0.81%0.9%1.94%
Acquisitions
-2.8M00-5.67M2.95M3.15M-8.22M-98.77M00
Investments
----------
Other Investing
-1.38M-2.15M0-2.35M-2.95M-3.15M0-3.73M-4.24M-3.19M
Cash from Financing
-4.34M-3.77M-7.65M102.37M-4.68M-7.62M-23.27M-6.57M-1.15M-1.43M
Debt Issued (Net)
0000000000
Equity Issued (Net)
0001000K1000K891K-1000K731K430K144K
Dividends Paid
-3.45M-4.16M-4.2M-4.25M-4.81M-4.85M-4.81M-4.8M00
Share Repurchases
000000-20M000
Other Financing
-888.6K388.25K-3.45M-1.13M-1.33M-3.67M1.54M-2.5M-1.58M-1.58M
Net Change in Cash
-1.81M▲ 0%
3.18M▲ 275.5%
2.03M▼ 36.1%
37.77M▲ 1756.3%
-12.22M▼ 132.4%
14.58M▲ 219.3%
5.96M▼ 59.2%
-47.21M▼ 892.7%
20.54M▲ 143.5%
24M▲ 0%
Free Cash Flow
5.32M▲ 0%
6.96M▲ 30.8%
9.68M▲ 39.1%
8.33M▼ 14.0%
14.63M▲ 75.6%
13.93M▼ 4.8%
17.58M▲ 26.2%
12.75M▼ 27.5%
17.41M▲ 36.5%
23.01M▲ 0%
FCF Margin %
22.03%23.46%28.5%20.02%31.48%25.84%29.51%18.22%21.99%29.24%
FCF Growth %
27.22%30.85%39.15%-14%75.65%-4.77%26.22%-27.46%36.53%167.68%
FCF per Share
0.300.390.540.450.710.670.860.630.871.14
FCF Conversion (FCF/Net Income)
1.19x1.04x1.36x1.17x1.96x1.43x2.19x1.34x-0.28x-0.36x
Interest Paid
0000000000
Taxes Paid
2.69M2.71M2.67M2.35M1.86M3.23M3.2M5.69M1.16M-112K

SLP Key Ratios

Simulations Plus, Inc. (SLP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
23.85%30.96%24.66%9.63%6.08%7.26%5.72%5.65%-42.13%-50.54%
Return on Invested Capital (ROIC)
36.15%36.68%32.75%12.99%7.1%8.66%5.41%3.21%-39.63%-44.87%
Gross Margin
73.87%73.05%73.43%74.39%77.19%79.92%80.48%61.63%58.38%59.6%
Net Margin
23.98%30.12%25.27%22.44%21.05%23.16%16.72%14.22%-81.74%-81.66%
Debt / Equity
---0.01x0.01x0.01x0.01x0.01x0.00x0.00x
Interest Coverage
216.41x---511.50x-----
FCF Conversion
1.19x1.04x1.36x1.17x1.96x1.43x2.19x1.34x-0.28x-0.36x
Revenue Growth
20.86%22.9%14.51%22.43%11.73%16.01%10.52%17.52%13.09%5.69%
Related:SLP Dividend History·SLP Revenue History·SLP Price History·SLP P/E History·SLP Financial Ratios·SLP Institutional Holders

SLP SEC Filings & Documents

Simulations Plus, Inc. (SLP) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 9, 2026·SEC

Material company update

Feb 18, 2026·SEC

Material company update

Jan 8, 2026·SEC

10-K Annual Reports

3
FY 2025

Dec 1, 2025·SEC

FY 2024

Oct 30, 2024·SEC

FY 2023

Oct 27, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 10, 2026·SEC

FY 2026

Jan 9, 2026·SEC

FY 2025

Jul 15, 2025·SEC

SLP Frequently Asked Questions

Simulations Plus, Inc. (SLP) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Simulations Plus, Inc. (SLP) reported $78.7M in revenue for fiscal year 2025. This represents a 2926% increase from $2.6M in 1996.

Simulations Plus, Inc. (SLP) grew revenue by 13.1% over the past year. This is steady growth.

Simulations Plus, Inc. (SLP) reported a net loss of $64.2M for fiscal year 2025.

Dividend & Returns

Simulations Plus, Inc. (SLP) has a return on equity (ROE) of -42.1%. Negative ROE indicates the company is unprofitable.

Simulations Plus, Inc. (SLP) generated $23.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in SLP back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in SLP be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →